Gladstone Institutional Advisory LLC Journey Medical Corp Transaction History
Gladstone Institutional Advisory LLC
- $2.07 Billion
- Q1 2025
A detailed history of Gladstone Institutional Advisory LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 36,854 shares of DERM stock, worth $314,733. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,854
Previous 29,981
22.92%
Holding current value
$314,733
Previous $121,000
79.34%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding DERM
# of Institutions
57Shares Held
6.87MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$15.8 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$9.84 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$7.38 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA565KShares$4.82 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA262KShares$2.24 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $99M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...